Your Dose of Cannabis Education
Your Dose of Cannabis Education
Only have a minute but want to Learn something every day™? Sign up to receive Your Dose of Cannabis Education, bringing featured content from our course library right to your inbox each day.
Your Dose of Cannabis Education is based on data from the studies and reviews published in the current peer-reviewed medical journals. Whether you are a healthcare provider, patient, caregiver, an individual working in the healthcare sector, or just a curious person, you can benefit from Your Dose of Cannabis Education.
Wake up every morning and get your dose of unbiased evidence-based cannabis education!
In contrast to oral Δ9-THC, orally administered CBD failed to lower IOP. "In a randomized, double-masked, placebo-controlled four-way crossover study, patients with ocular hypertension or early primary open-angle glaucoma received a single sublingual dose of 5 mg Δ9-THC, 20 mg CBD, 40 mg CBD, or placebo. In this study, CBD did not exert an IOP-lowering effect, and the higher dose of 40 mg CBD resulted in a transient increase in IOP 4 h after administration."No. According to a 2024 literature review, "The studies so far have not been able to provide evidence of an unequivocal benefit large enough to place cannabis derivatives as a second- or third-line option in the treatment of glaucoma.""Studies in the 1970s identified conjunctival hyperemia, decreased lacrimation, diplopia, impairment of accommodation, photophobia, nystagmus, and blepharospasm as adverse effects of topical, oral,
systemic, and inhalational use of marijuana or THC.""In the human eye, cannabinoid receptors are expressed in the retina, ciliary body, iris, Schlemm’s canal, trabecular meshwork, and retinal pigment epithelium. Because of the location and crucial anatomical distribution of cannabinoid receptors, cannabinoids can affect IOP by both reducing the generation of aqueous humor
and enhancing its outflow."According to a 2024 publication, "more than three quarters of Americans now live in a county with a cannabis dispensary, and, for the second year in a row, nationally representative self-reported data on substance use show daily or near-daily cannabis use surpassed daily or near-daily alcohol use in the United States in 2023."
feed…New to TheAnswerPage? There’s lots we’d like to share with you and we don’t want you to miss a thing! Be sure to register today for “Your Dose of Cannabis Education” emails where you’ll gain valuable insights in small doses that fit your schedule and also be provided direct access to the archived daily content.